on Affluent Medical (isin : FR0013333077)
Carvolix is included in Euronext indices, strengthening its financial visibility
Carvolix, formerly Affluent Medical, has announced its inclusion in the Euronext CAC® Small, CAC® Mid & Small, and CAC® All-Tradable indices. This inclusion, effective March 23, 2026, marks a significant milestone for the French company specializing in medical technologies, particularly AI-based mini-robots and biomimetic implants.
This development is intended to increase the stock's liquidity and attract a wider range of investors, particularly through greater visibility among index funds. CEO Sébastien Ladet emphasizes that this recognition supports Carvolix's ambition. The company aims to democratize access to its robotic solutions for treating structural heart disease and strokes.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news